Dr. Helen H. Hobbs has been awarded the 2016 Breakthrough Prize in Life Sciences for her work defining genetic variants responsible for altered levels and distribution of cholesterol. The 3 million dollar prize, founded by Silicon Valley philanthropists Sergey Brin, Anne Wojcicki, Jack Ma, Cathy Zhang, Mark Zuckerberg, Priscilla Chan and Yuri and Julia Milner, is awarded to individuals who have challenged conventional thinking and pioneered research in science and math. Dr. Hobb’s ground breaking work has been instrumental in the development of new LDL lowering drugs. She is Director of the Dallas Heart Study and a former UTSW chief resident. We are proud to call her our own and wish her infinite success with her future research endeavors.